Snoozeal® is a non-invasive intraoral neuromuscular stimulation device with clinically proven reduction of primary snoring and mild obstructive sleep apnoea.
Snoozeal® challenges the wisdom of conventional snoring solutions. It is the first, unique daytime treatment for sleep disordered breathing that uses an entirely novel and original method – physiologically retraining the airway against collapse.
Now patients can benefit from this convenient and effective therapy so that they and their partners can get a better night’s sleep.
Snoozeal® is a user controllable neuromuscular electrical stimulator (NMES) that delivers a mild electrical current with defined frequencies to stimulate and improve muscle function in the mouth and tongue.
Unlike traditional snoring therapies, Snoozeal® strengthens tongue and throat muscle tone, to prevent excessive muscle relaxation during sleep, reducing airway collapse.
A daytime therapy with no night-time wearable necessary for a better night’s sleep.
Snoozeal® has been clinically proven to improve the quality of sleep by reducing snoring and sleep apnoea significantly, when used for 20 minutes, once a day for 6 weeks 1-3
Location: Essen, Germany and Nottingham, UK
Cohort: 30 patients
Documents: CHEST Presentation, Publication, Original Paper
Location: London, UK
Cohort: 50 patients